Are you Dr. Hudes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 89 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 215-728-6900Fax+1 215-728-3639- Is this information wrong?
Summary
- Dr. Gary Hudes, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Temple University Hospital and is a Medical Oncologist at Pennsylvania. Affiliated with multiple hospitals in the area.
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1983 - 1985
- Temple University HospitalFellowship, Hematology and Medical Oncology, 1982 - 1983
- Graduate HospitalResidency, Internal Medicine, 1979 - 1982
- State University of New York Downstate Medical Center College of MedicineClass of 1979
Certifications & Licensure
- PA State Medical License 1980 - 2016
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 1999 Feb 04
- R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Apr 01
- Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer Start of enrollment: 2001 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPhase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N. Stein, Yu-Hui Chen, Michael A. Carducci, Gary R. Hudes, Pauline M. Lerma, Winston Tan, Robert Dalune, Kendrith M. Rowland, Timothy M. Kuzel, Robert S. DiPaola> ;American Journal of Clinical Oncology. 2019 Apr 1
- 1 citationsPhase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.Yu-Ning Wong, Judith Manola, Gary R. Hudes, Bruce J. Roth, Judd W. Moul, Andrea M. Barsevick, Richard Scher, Michael J. Volk, David J. Vaughn, Stephen D. Williams, Mic...> ;Clinical Genitourinary Cancer. 2018 Apr 1
- 25 citationsHydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells.Hyung-Ok Lee, Aladdin Mustafa, Gary R. Hudes, Warren D. Kruger> ;Plos One. 2015 Jul 2
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Temple University HospitalPhiladelphia, Pennsylvania